From: Expression of ck-19, galectin-3 and hbme-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis
ICC ANALYSIS
STUDIES
PATIENTS
TP
FP
FN
TN
CK-19[31, 62, 63]
3
230
111 (48.3%)
19 (8.3%)
27 (11.7%)
73 (31.7%)
GAL-3[31, 64–75]
14
1785
581 (33.9%)
103 (6.0%)
104 (6.0%)
927 (54.1%)
HBME-1[31, 62, 64, 66, 74, 76, 77]
7
3900
1501 (38.5%)
324 (8.3%)
436 (11.2%)
1639 (42.0%)
